<DOC>
	<DOCNO>NCT02422602</DOCNO>
	<brief_summary>This study multicentric , single-blind , interventionnal randomization two parallel arm , standard care information additionnal information patient , 12 month follow . The aim study evaluate effectiveness personalize information programm versus information provide standard care patient take Xarelto Stroke Prevention Atrial Fibrillation .</brief_summary>
	<brief_title>Better Adherence With New Oral Anticoagulant Atrial Fibrillation : Effectiveness Personalized Education Program</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>All patient treat rivaroxaban chronically , ( atrial fibrillation nonvalvular current AMM ) less one year whatever anti vitamin K treatment history Affiliate beneficiary social security system . Patient formulate `` oppose '' participate research Age high equal 18 year Opposition participation Patient n't understand french language Patient responsibility management treatment ( treatment administer nurse home , caregiver ) Tutorship curatoship Lawprotected patient Pregnant woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Patients</keyword>
	<keyword>treat Rivaroxaban</keyword>
</DOC>